Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ksenija Gersak

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Biomedical Reports|March 21, 2014
Association of -108 C>T <i>PON1</i> polymorphism with polycystic ovary syndromePolonca Ferk, Ksenija Gersak
Journal of Perinatal Medicine|November 28, 2012
Can prenatal detection of Down syndrome be improved by enhancing obstetricians' skills of performing adequate foetal cardiac examination at the primary level?Ksenija Gersak, Samo Vesel
Human Reproduction (Oxford, England)|December 26, 2006
The (TAAAA)n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndromePolonca Ferk, Natasa Teran, Ksenija Gersak
Journal of Assisted Reproduction and Genetics|January 5, 2006
No association between the microsatellite polymorphism (TTTTA)n in the promoter of the CYP11A gene and ovarian hyperstimulation syndromePolonca Ferk, Ksenija Gersak, Natasa Teran
Reproductive Toxicology (Elmsford, N.Y.)|June 4, 2009
Angiotensin II receptor blockers in pregnancy: a report of five casesKsenija Gersak, Marta Cvijic, Lilijana Kornhauser Cerar
Journal of Perinatal Medicine|February 9, 2008
Risk assessment of trisomy 21 by maternal age and fetal nuchal translucency thickness in 7,096 unselected pregnancies in SloveniaDarija M Strah, Maja Pohar, Ksenija Gersak
Human Reproduction (Oxford, England)|July 23, 2003
Fragile X premutation in women with sporadic premature ovarian failure in SloveniaKsenija Gersak, Helena Meden-Vrtovec, Borut Peterlin
Cancer Biomarkers : Section a of Disease Markers|October 21, 2011
The influence of the genetic variant within miRNA-binding site in estrogen receptor alpha gene on the risk of breast cancer in postmenopausal women on hormone replacement therapyJasmina-Ziva Cerne, Ksenija Gersak, Srdjan Novakovic
Pathology Oncology Research : POR|June 17, 2011
Breast tumor characteristics in hormone replacement therapy usersJasmina-Ziva Cerne, Snjezana Frkovic-Grazio, Ksenija Gersak
BMC Cancer|March 23, 2012
KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control studyJasmina-Ziva Cerne, Vida Stegel, Ksenija Gersak, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Biomedical Reports|March 21, 2014
Association of -108 C>T <i>PON1</i> polymorphism with polycystic ovary syndromePolonca Ferk, Ksenija Gersak
Journal of Perinatal Medicine|November 28, 2012
Can prenatal detection of Down syndrome be improved by enhancing obstetricians' skills of performing adequate foetal cardiac examination at the primary level?Ksenija Gersak, Samo Vesel
Human Reproduction (Oxford, England)|December 26, 2006
The (TAAAA)n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndromePolonca Ferk, Natasa Teran, Ksenija Gersak
Journal of Assisted Reproduction and Genetics|January 5, 2006
No association between the microsatellite polymorphism (TTTTA)n in the promoter of the CYP11A gene and ovarian hyperstimulation syndromePolonca Ferk, Ksenija Gersak, Natasa Teran
Reproductive Toxicology (Elmsford, N.Y.)|June 4, 2009
Angiotensin II receptor blockers in pregnancy: a report of five casesKsenija Gersak, Marta Cvijic, Lilijana Kornhauser Cerar
Journal of Perinatal Medicine|February 9, 2008
Risk assessment of trisomy 21 by maternal age and fetal nuchal translucency thickness in 7,096 unselected pregnancies in SloveniaDarija M Strah, Maja Pohar, Ksenija Gersak
Human Reproduction (Oxford, England)|July 23, 2003
Fragile X premutation in women with sporadic premature ovarian failure in SloveniaKsenija Gersak, Helena Meden-Vrtovec, Borut Peterlin
Cancer Biomarkers : Section a of Disease Markers|October 21, 2011
The influence of the genetic variant within miRNA-binding site in estrogen receptor alpha gene on the risk of breast cancer in postmenopausal women on hormone replacement therapyJasmina-Ziva Cerne, Ksenija Gersak, Srdjan Novakovic
Pathology Oncology Research : POR|June 17, 2011
Breast tumor characteristics in hormone replacement therapy usersJasmina-Ziva Cerne, Snjezana Frkovic-Grazio, Ksenija Gersak
BMC Cancer|March 23, 2012
KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control studyJasmina-Ziva Cerne, Vida Stegel, Ksenija Gersak, et al.
Pageof 5